Several studies have shown the elevated expression level and cancer promotion effect of EZH2 in HCC, mainly through the polycomb repressive complex 2 (PRC2)-dependent roles as transcriptional repressors (10–13). The gene discussed is EZH2; the disease is hepatocellular carcinoma.